Conclusions

Beneficial effects of immunotherapy in human sepsis and septic shock have not been demonstrated despite animal evidence and immediate hemodyamic improvements suggesting that benefits would occur. This may be related to the complex interaction of cytokines with each other and with other drugs such as sympathomimetics, or real benefits may be concealed by the limitations of clinical trials in human multisystem disease of variable severity. The high cost of such drugs means that approval for use in multisystem disease is unlikely in the absence of demonstration of improved survival. Although these novel biological immunotherapies do have a role to play in conditions other than infection and sepsis, the approved indications are currently limited.

Kicking Fear And Anxiety To The Curb

Kicking Fear And Anxiety To The Curb

Kicking Fear And Anxiety To The Curb Can Have Amazing Benefits For Your Life And Success. Learn About Calming Down And Gain Power By Learning Ways To Become Peaceful And Create Amazing Results.

Get My Free Ebook


Post a comment